FDA DOING "GOOD JOB" AT MEETING USER FEE REVIEW TIME GOALS -- PhRMA's MOSSINGHOFF; 80% OF 1995 USER FEE BIOLOGICS GAINING APPROVALS WITHIN TIMEFRAME
Executive Summary
FDA is continuing to make "significant progress in bringing down review times" and meeting goals set by the user fee act, Pharmaceutical Research & Manufacturers of America President Gerald Mossinghoff said at a Jan. 17 press briefing in Washington, D.C.